{"id":850,"date":"2020-04-17T13:36:00","date_gmt":"2020-04-17T17:36:00","guid":{"rendered":"https:\/\/www.mesotheliomahope.com\/?page_id=850"},"modified":"2025-09-19T00:28:30","modified_gmt":"2025-09-19T04:28:30","slug":"dr-claire-verschraegen","status":"publish","type":"page","link":"https:\/\/www.mesotheliomahope.com\/treatment\/doctors\/dr-claire-verschraegen\/","title":{"rendered":"Dr. Claire Verschraegen"},"content":{"rendered":"<h2>About Dr. Verschraegen<\/h2>\n<p>Dr. Verschraegen has over 30 years of experience working in drug development and clinical research. During this time, she has conducted extensive research into how chemotherapy drugs, such as pemetrexed (Alimta) and gemcitabine, can be combined to effectively treat <a href=\"\/mesothelioma\/\">mesothelioma<\/a> in many patients.<\/p>\n<blockquote><p>\u201cIn my 30 years of being an academic medical oncologist, incredible progress has been made in a few areas \u2014 most notably including some leukemias, lung cancer, and melanoma, where novel targeted therapies and immunotherapies have transformed cancer from dreadful to possibly curable.\u201d<\/p>\n<footer><cite><strong>&ndash; Dr. Claire Verschraegen, mesothelioma specialist<\/strong><\/cite><\/footer><\/blockquote><style type=\"text\/css\">blockquote{margin:40px 0;padding:0px 15px 0px 60px;position:relative;background-color:#fff}blockquote:before{content:\"\\e99d\";color:#fff;background-color:#0FAEBF;font-size:30px;font-family:\"mesohope\" !important;position:absolute;left:0;top:0;width:50px;height:50px;line-height:50px;text-align:center;border-radius:50%}blockquote p{margin:0}blockquote footer cite{font-size:inherit;line-height:26px;font-style:normal}@media screen and (min-width: 1024px){blockquote{padding:0px 90px 0px 85px}blockquote:before{font-size:35px;width:60px;height:60px;line-height:60px;left:0}}<\/style>\n<p>Download our free\u00a0<strong>questions to ask a mesothelioma doctor\u00a0<\/strong>checklist to get the answers you need about fighting this rare cancer.<\/p>\n<div data-vqueid=\"18575\" class=\"widget widget_oscar-vque outline image-left has-img\"><style type=\"text\/css\" data-style=\"outline\">.widget_oscar-vque.outline{margin:60px auto;max-width:315px}.widget_oscar-vque.outline:first-child{margin-top:0}.widget_oscar-vque.outline:last-child{margin-bottom:0}.widget_oscar-vque.outline>a{border:1px solid #E6E7EC;padding:20px;box-shadow:0 20px 20px rgba(34,34,34,0.03);border-radius:10px;color:#383441;display:block;text-decoration:none}.widget_oscar-vque.outline img{margin:0 auto 20px;max-width:180px}.widget_oscar-vque.outline .vque-content{color:#383441;font-size:16px;text-align:center}.widget_oscar-vque.outline strong.subheading{color:#100134;display:block;line-height:1;font-size:14px;margin-bottom:5px}.widget_oscar-vque.outline strong.heading{color:#100134;font-size:20px;display:block;margin:0 0 20px}.widget_oscar-vque.outline ul{font-size:16px;text-align:left;list-style:none;max-width:265px;margin:15px auto 25px}.widget_oscar-vque.outline ul li{padding-left:28px;margin-bottom:10px}.widget_oscar-vque.outline ul li:last-child{margin-bottom:0}.widget_oscar-vque.outline ul li:before{font-family:\"mesohope\" !important;font-display:swap;speak:none;color:#fff;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;content:\"\\e904\";border:none;position:absolute;left:0;top:3px;background:#0FAEBF;width:20px;height:20px;border-radius:20px;line-height:20px;text-align:center;font-size:12px}.widget_oscar-vque.outline strong.button.arrow{width:100%}.widget_oscar-vque.outline.image-left>a{position:relative;border-radius:0 10px 10px 0}.widget_oscar-vque.outline.image-left>a:before{content:\" \";position:absolute;top:0;bottom:0;width:4px;height:100%;left:0;background:linear-gradient(180deg, #0FAEBF 0%, #fff 100%)}@media screen and (min-width: 768px){.widget_oscar-vque.outline{max-width:620px}.widget_oscar-vque.outline img{max-width:100%}.widget_oscar-vque.outline>a{padding:0}.widget_oscar-vque.outline>a>div{display:block;display:flex;flex-wrap:wrap;align-items:flex-end;flex-direction:row-reverse}.widget_oscar-vque.outline>a>div>div{width:41%}.widget_oscar-vque.outline>a .vque-content{width:59%;padding:30px;text-align:left}.widget_oscar-vque.outline strong.subheading{font-size:16px}.widget_oscar-vque.outline strong.heading{font-size:24px;margin:0 0 13px}.widget_oscar-vque.outline ul{max-width:none}.widget_oscar-vque.outline strong.button.arrow{width:auto}.widget_oscar-vque.outline.image-left>a>div{display:block;position:relative;overflow:hidden}.widget_oscar-vque.outline.image-left>a>div>div{float:left}.widget_oscar-vque.outline.image-left>a>div>div:first-child{width:27%;padding:30px}.widget_oscar-vque.outline.image-left>a>div>div.vque-content{width:73%;padding-left:0;color:#383441}}<\/style><a href=\"\/doctor-questions\/\" title=\"Free Download: 14 Questions to Ask\u00a0Your Doctor\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Free Download: 14 Questions to Ask\u00a0Your Doctor Ad\" data-desktop-image=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2021\/05\/questions-to-ask-doctor-ipad.png\"><div><div><img loading=\"lazy\" decoding=\"async\" width=\"95\" height=\"144\" src=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2021\/05\/questions-to-ask-doctor-ipad.png\" class=\"attachment-Medium size-Medium wp-post-image\" alt=\"14 Questions to Ask Your Doctor packet\" \/><\/div><div class=\"vque-content\"><strong class=\"heading\">Free Download: 14 Questions to Ask\u00a0Your Doctor<\/strong><ul>\n<li>Preparing for treatment<\/li>\n<li>Finding clinical trials<\/li>\n<li>Getting a second opinion<\/li>\n<\/ul>\n<p><strong class=\"button yellow arrow\" title=\"Get Your Free Download\">Get Your Free Download<\/strong><\/p><\/div><\/div><\/a><\/div>\n<h3>Dr. Verschraegen\u2019s Location<\/h3>\n<p>Dr. Verschraegen offers <a href=\"\/treatment\/states\/ohio\/\">Ohio mesothelioma treatment<\/a> at The Ohio State University Comprehensive Cancer Center in Columbus.<\/p>\n<p><strong>The James Cancer Hospital and Solove Research Institute<\/strong><br \/>\n460 West 10th Avenue<br \/>\nColumbus, Ohio 43210<br \/>\n<em>(614) 293-0463<\/em><\/p>\n<p>She also treats patients at Ohio State Martha Morehouse Outpatient Care.<\/p>\n<p><strong>Ohio State Martha Morehouse Outpatient Care<\/strong><br \/>\n2050 Kenny Road<br \/>\nColumbus, OH 43221<br \/>\n<em>(614) 293-3890<\/em><\/p>\n<h2 id=\"career-highlights\">Career Highlights<\/h2>\n<p><strong>Over her career, Dr. Verschraegen has:<\/strong><\/p>\n<ul class=\"special diamond\">\n<li>Completed extensive research on the drugs Alimta and <a href=\"\/treatment\/chemotherapy\/drugs\/gemcitabine\/\">gemcitabine<\/a>, concluding it is often an effective treatment for peritoneal mesothelioma<\/li>\n<li>Directed numerous leading medical institutions, including the Ohio State University Comprehensive Cancer Center and the New Mexico Cancer Center<\/li>\n<li>Recognized as an academic leader within the medical community with more than 80 peer-reviewed articles, in addition to 20 invited articles and 10 book chapters<\/li>\n<\/ul>\n<h2 id=\"professional-background\">Dr. Verschraegen\u2019s Background<\/h2>\n<p>Dr. Verschraegen holds a medical degree from Universit\u00e9 Libre de Bruxelles in Belgium, where she graduated magna cum laude.<\/p>\n<p>After completing an internal medicine internship at the Institut Jules Bordet, she completed an internal medicine residency at the University of Houston and a fellowship in cancer research from the Stehlin Foundation for Cancer Research.<\/p>\n<p>She completed a second fellowship at the University of Texas MD Anderson Cancer Center in medical oncology, remaining at MD Anderson for the next seven years. Dr. Verschraegen later served as medical director at the New Mexico Cancer Care Alliance and director of Translational Therapeutics and Clinical Research at the University of New Mexico Cancer Center.<\/p>\n<p>At the University of Vermont, Dr. Verschraegen oversaw the Phase 1 clinical trials program, was the Irwin H. Krakoff, MD, Endowed Green &amp; Gold Professor of Medicine, and directed the hematology\/oncology division. She was also deputy director of the University of Vermont Cancer Center.<\/p>\n<p>Dr. Verschraegen currently works at the Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital (OSUCCC \u2013 James) and Richard J. Solove Research Institute. She is their director of medical oncology and associate director of the translational research program.<\/p>\n<p><strong>Dr. Verschraegen is a member of:<\/strong><\/p>\n<ul class=\"special diamond\">\n<li>Alliance for Clinical Trials in Oncology<\/li>\n<li>Education Committee of the International Gynecologic Cancer Society (IGCS)<\/li>\n<li>European Organisation for Research and Treatment of Cancer (EORTC)<\/li>\n<li>Gynecologic Oncology Group (GOG Foundation)<\/li>\n<li>Scientific Board of the Mesothelioma Applied Research Foundation<\/li>\n<li>SWOG (formerly Southwest Oncology Group)<\/li>\n<\/ul>\n<h3>Medical Specializations<\/h3>\n<p>Dr. Verschraegen\u2019s extensive background in medical oncology gives her several unique areas of focus. She is best known for her innovative clinical trial work and academic findings. She has focused on anti-cancer drug development, as well as treatments for peritoneal mesothelioma and other forms of cancer.<\/p>\n<p>Connect with top mesothelioma doctors using our <strong>Free Doctor Match service<\/strong>.<\/p>\n<div id=\"25223\" class=\"one-off-25223 widget widget_oscar-vque one-off\" data-vqueid=\"25223\"><style type=\"text\/css\" data-style=\"one-off\">.one-off-25223{margin:60px auto}.one-off-25223 a{box-shadow:0 4px 4px 0 rgba(0,0,0,.25);display:block;background:#e4f4f6;padding:20px 25px 200px;text-decoration:none;color:inherit;position:relative;overflow:hidden;max-width:360px;margin:0 auto}.one-off-25223 a::before{background:#0FAEBF;border-radius:50% 50% 0 0;content:'';position:absolute;bottom:0;height:19%;width:135%;left:-60px;z-index:0}.one-off-25223 .vque-content,.one-off-25223 .image-wrap{z-index:1;position:relative}.one-off-25223 .image-wrap{width:100%;position:absolute;left:-10px;bottom:-15px}.one-off-25223 .image-wrap img{position:absolute;bottom:0;width:100%;max-width:unset;left:0}.one-off-25223 .heading{font-size:27px;line-height:33px;text-align:center;display:block;max-width:340px;margin:5px auto 25px}.one-off-25223 ul{list-style:none;margin:-10px auto 22px;text-align:left;font-size:16px;line-height:26px}.one-off-25223 ul li{margin:0 0 15px;position:relative;padding-left:35px}.one-off-25223 ul li::before{font-family:\"mesohope\"!important;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;content:\"\\e904\";background:#0FAEBF;width:21px;height:21px;display:block;position:absolute;left:0;top:4px;border-radius:50%;color:#fff;font-size:11px;text-align:center;line-height:21px}.one-off-25223 p{text-align:center}.one-off-25223 .button{padding:12px 16px;display:block}@media screen and (min-width:768px){.one-off-25223 a{max-width:620px;padding:30px 30px 35px;border-radius:0 0 4px 4px}.one-off-25223 a::before{border-radius:50%;height:155%;width:150%;right:-550px;left:unset;bottom:-295px}.one-off-25223 .heading{text-align:left;margin:2px 0 25px;max-width:unset;font-size:24px}.one-off-25223 ul{margin:-7px 0 30px;max-width:365px;line-height:23px}.one-off-25223 ul li::before{top:1px}.one-off-25223 .image-wrap{max-width:unset;position:absolute;right:-25px;bottom:-35px;margin:0 0 -2px;left:unset;width:380px}.one-off-25223 .image-wrap img{position:relative;bottom:0;left:0;width:380px}.one-off-25223 .button{display:inline-block;padding:14px 25px}.one-off-25223 p{text-align:left}}@media screen and (min-width:1150px){.one-off-25223 a{padding:30px}}<\/style><a href=\"\/get-matched\/\" title=\"Get Matched With a Mesothelioma Doctor\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Get Matched With a Mesothelioma Doctor Ad\"><div>\r\n    <div class=\"vque-content\">\r\n        <strong class=\"heading\">Get Matched With a Mesothelioma Doctor<\/strong>\r\n        <ul>\r\n            <li>Find top specialists near you<\/li>\r\n            <li>Seek compensation for travel & care<\/li>\r\n            <li>Get medical guidance<\/li>\r\n        <\/ul>\r\n        <p><strong class=\"button arrow\" title=\"Get Matched Now\">Get Matched Now<\/strong><\/p>\r\n    <\/div>\r\n    <div class=\"image-wrap\"><img decoding=\"async\"  src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"\/wp-content\/uploads\/2024\/07\/Doctors-ad.png\" alt=\"Get Matched With a Mesothelioma Doctor\" class=\"lazyload\" ><\/div>\r\n<\/div><\/a><\/div>\n<h2>Career Accomplishments<\/h2>\n<p>Dr. Verschraegen is a highly accomplished academic oncologist. She has held illustrious positions at some of the world\u2019s top cancer facilities. She has been the principal investigator for numerous clinical trials and is noted for her work with New Mexico\u2019s Community Clinical Oncology Program, providing clinical trial access to those in need.<\/p>\n<p>Her ability to receive continuous funding for Phase I, II, and III clinical trials are extraordinary, especially for cancers like mesothelioma that have been traditionally challenging to support due to their rarity.<\/p>\n<p>Dr. Verschraegen continues to educate residents and fellows and routinely shares her new findings with the medical community.<\/p>\n<h2>Awards &amp; Honors<\/h2>\n<ul class=\"special diamond\">\n<li>America&#8217;s Top Doctors<\/li>\n<li>America&#8217;s Top Doctors for Cancer<\/li>\n<li>CMS Stage 1 EHR<\/li>\n<li>Fullbright Fellowship<\/li>\n<li>Occino-Kernkamp Prize &#8211; Belgium Association of University Women<\/li>\n<\/ul>\n<p>Dr. Verschraegen currently oversees the Division of Medical Oncology at the OSUCCC \u2013 James, serving as the Diane Nye and Michael Rayden Chair in Innovative Cancer Research.<\/p>\n<p>She leads over 50 faculty members who practice a wide range of cancer care and research specialties. She continues to be involved in numerous clinical trials and publications and is an active academic medical oncologist.<\/p>\n<h2 id=\"notable-clinical-trials\">Notable Clinical Trials<\/h2>\n<p>Dr. Verschraegen is a true believer in funding clinical trials to develop new and innovative ways of treating people. She also believes in the power of recruiting participants for clinical trials so that researchers can actually follow through with and analyze their experimental therapies.<\/p>\n<div class=\"did-you-know icon-pen\"><style type=\"text\/css\">.did-you-know{background:#F3F2F0;border-radius:10px;margin:40px 0;padding:20px 20px 20px 80px;position:relative}.did-you-know:before{position:absolute;left:20px;top:20px;width:45px;height:45px;background:#0FAEBF;border-radius:50px;color:#fff;text-align:center;line-height:45px;font-size:27px}.did-you-know .heading{font-size:24px;color:#100134;padding:10px 0;display:block;margin:0 0 5px}.did-you-know h2,.did-you-know .h2,.did-you-know h3,.did-you-know .h3{font-size:24px;line-height:1.14}@media screen and (min-width: 1024px){.did-you-know{padding:25px 25px 25px 90px}.did-you-know:before{left:25px;top:25px}.did-you-know .heading{padding:8px 0}.did-you-know h2,.did-you-know .h2,.did-you-know h3,.did-you-know .h3{font-size:24px;line-height:1.14}}<\/style><strong class=\"heading\">Clinical Trials Update<\/strong><p>Dr. Verschraegen&#8217;s most notable clinical trial was the testing of a new chemotherapy drug combination for peritoneal mesothelioma. She and her team of researchers tested a chemotherapy drug combination of Alimta and gemcitabine.<\/p>\n<\/div>\n<p>This approach was significant because up until this clinical trial, the only other approved drug combination for peritoneal mesothelioma was pemetrexed and cisplatin, another chemotherapy drug.<\/p>\n<p>But because patient response varies between different drug types, it is important for researchers to find new and effective drug combinations that can be tolerated by other patients.<\/p>\n<p>These two <a href=\"https:\/\/www.mesotheliomahope.com\/treatment\/chemotherapy\/drugs\/\">chemotherapy drugs<\/a> were chosen because they have demonstrated synergistic effects, meaning they become more effective together than each one is on its own. The results of this drug combination were promising, indicating that peritoneal mesothelioma patients could improve their median survival times with this approach.<\/p>\n<p>Learn more about clinical trials and mesothelioma treatments in our <strong>Free Mesothelioma Guide<\/strong>, shipped to your door overnight.<\/p>\n<div data-vqueid=\"1361\" class=\"widget widget_oscar-vque default image-right has-img\"><style type=\"text\/css\" data-style=\"default\">.widget_oscar-vque.default{margin:60px auto;max-width:315px}.widget_oscar-vque.default:first-child{margin-top:0}.widget_oscar-vque.default:last-child{margin-bottom:0}.widget_oscar-vque.default>a{background:#2F293D;display:block;padding:20px;border-radius:10px;color:#fff;text-decoration:none}.widget_oscar-vque.default img{margin:0 auto 20px;max-width:150px;width:100%}.widget_oscar-vque.default .vque-content{font-size:16px;text-align:center}.widget_oscar-vque.default strong.subheading{display:block;line-height:1;font-size:14px;margin-bottom:5px}.widget_oscar-vque.default strong.heading{font-size:20px;display:block;margin:0 0 25px}.widget_oscar-vque.default ul{font-size:16px;text-align:left;list-style:none;max-width:265px;line-height:1.4;margin:15px auto 25px}.widget_oscar-vque.default ul li{padding-left:28px;margin-bottom:10px}.widget_oscar-vque.default ul li:last-child{margin-bottom:0}.widget_oscar-vque.default ul li:before{font-family:\"mesohope\" !important;font-display:swap;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;content:\"\\e904\";border:none;position:absolute;left:0;top:0;background:#0FAEBF;width:20px;height:20px;border-radius:20px;line-height:20px;text-align:center;font-size:12px}.widget_oscar-vque.default strong.button.arrow{width:100%}@media screen and (min-width: 768px){.widget_oscar-vque.default{max-width:620px}.widget_oscar-vque.default>a{padding:0}.widget_oscar-vque.default>a>div{display:block;display:flex;align-items:center;flex-wrap:wrap;flex-direction:row-reverse}.widget_oscar-vque.default>a>div>div{padding:0 25px 0 0;width:41%}.widget_oscar-vque.default>a .vque-content{width:59%;padding:30px;text-align:left}.widget_oscar-vque.default img{max-width:90%;margin-bottom:0}.widget_oscar-vque.default strong.subheading{font-size:16px}.widget_oscar-vque.default strong.heading{font-size:24px;margin:0 0 16px}.widget_oscar-vque.default ul{max-width:none}.widget_oscar-vque.default strong.button.arrow{width:auto}.widget_oscar-vque.default.image-left>a>div{display:block;position:relative;overflow:hidden}.widget_oscar-vque.default.image-left>a>div img{max-width:100%}.widget_oscar-vque.default.image-left>a>div>div{float:left}.widget_oscar-vque.default.image-left>a>div>div:first-child{width:27%;padding:30px}.widget_oscar-vque.default.image-left>a>div>div.vque-content{width:73%;padding-left:0}}<\/style><a href=\"\/mesothelioma-guide\/\" title=\"Get Your Free 2026 Mesothelioma Guide\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Get Your Free 2026 Mesothelioma Guide Ad\" data-desktop-image=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/07\/guide-image-vertical.png\"><div><div><div class=\"image-fade\"><img loading=\"lazy\" decoding=\"async\" width=\"296\" height=\"290\" src=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/07\/guide-image-vertical.png\" class=\"attachment-Medium size-Medium wp-post-image\" alt=\"Mesothelioma Guide Images\" srcset=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/07\/guide-image-vertical.png 296w, https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/07\/guide-image-vertical-55x55.png 55w, https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/07\/guide-image-vertical-102x100.png 102w\" sizes=\"(max-width: 296px) 100vw, 296px\" \/><\/div><\/div><div class=\"vque-content\"><strong class=\"heading\">Get Your Free 2026 Mesothelioma Guide<\/strong><ul>\n<li>Symptoms &amp; staging<\/li>\n<li>Average prognosis<\/li>\n<li>Life-extending treatments<\/li>\n<\/ul>\n<p><strong class=\"button arrow\" title=\"Get Your Free Guide\">Get Your Free Guide<\/strong><\/p><\/div><\/div><\/a><\/div>\n<h2 id=\"healing-philosophy\">Dr. Verschraegen\u2019s Healing Philosophy<\/h2>\n<p>Dr. Verschraegen is a vital advocate for the advancement of mesothelioma research and treatment. Her dedication to developing, promoting, and ultimately completing clinical trial tests on new therapies has been critical.<\/p>\n<blockquote><p>\u201cThere is always hope, especially with the new therapies that are available.\u201d<\/p>\n<footer><cite><strong>&ndash; Dr. Claire Verschraegen, mesothelioma specialist<\/strong><\/cite><\/footer><\/blockquote><style type=\"text\/css\">blockquote{margin:40px 0;padding:0px 15px 0px 60px;position:relative;background-color:#fff}blockquote:before{content:\"\\e99d\";color:#fff;background-color:#0FAEBF;font-size:30px;font-family:\"mesohope\" !important;position:absolute;left:0;top:0;width:50px;height:50px;line-height:50px;text-align:center;border-radius:50%}blockquote p{margin:0}blockquote footer cite{font-size:inherit;line-height:26px;font-style:normal}@media screen and (min-width: 1024px){blockquote{padding:0px 90px 0px 85px}blockquote:before{font-size:35px;width:60px;height:60px;line-height:60px;left:0}}<\/style>\n<p>She understands the importance of finding and recruiting patients to participate in clinical trials for the betterment of all patients. She believes that patients deserve the best, most effective treatments possible and understands the significant role that clinical trials play in achieving this goal.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>About Dr. Verschraegen Dr. Verschraegen has over 30 years of experience working in drug development and clinical research. During this time, she has conducted extensive research into how chemotherapy drugs, such as pemetrexed (Alimta) and gemcitabine, can be combined to effectively treat mesothelioma in many patients. Download our free\u00a0questions to ask a mesothelioma doctor\u00a0checklist to&hellip;<\/p>\n","protected":false},"author":49,"featured_media":20939,"parent":49,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-doctor.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-850","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages\/850","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/comments?post=850"}],"version-history":[{"count":0,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages\/850\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages\/49"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/media\/20939"}],"wp:attachment":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/media?parent=850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}